Turkey Apparel Industry

Business

Therapeutics Sector Shows Resilience in Q3: United Therapeutics Lags as Halozyme and Biogen Outperform

A mixed third-quarter earnings season for therapeutics stocks reveals divergent paths, with United Therapeutics missing estimates while peers like Halozyme and Biogen post strong beats. Sector-wide revenue growth and positive stock reactions suggest underlying investor confidence despite regulatory and pricing headwinds.

Jan 30, 2026

World

Iran Draws Red Line on Missile Program as U.S. Naval Buildup Intensifies

Amid escalating tensions and a U.S. military buildup in the Gulf, Iran's foreign minister has declared the country's missile capabilities 'non-negotiable,' setting the stage for a precarious diplomatic standoff.

Jan 30, 2026

Business

Haemonetics Gains Analyst Backing After Strategic Vivasure Buyout

Haemonetics (NYSE:HAE) sees its price target raised by Barrington Research following its acquisition of Vivasure Medical, with analysts highlighting the deal's potential to bolster its medical device portfolio and drive growth.

Jan 30, 2026

Business

U.S. Drilling Activity Stalls Amid Mixed Signals for Oil and Gas

The U.S. rig count saw a marginal increase this week, yet remains significantly below last year's levels as crude production dips and completions activity sends conflicting signals.

Jan 30, 2026

Business

Campbell's to Close Historic Cape Cod Chip Plant, Ending a Local Era

Campbell Soup Company will shutter its Hyannis, Massachusetts facility, the original home of Cape Cod Potato Chips, citing economic inefficiency. The closure, affecting 49 jobs, marks a strategic shift of production to larger plants as the snack giant consolidates its network.

Jan 30, 2026

Business

Advocate Health Announces Major Compensation Overhaul, Boosting Minimum Wage and Benefits Across Six States

Advocate Health, the nation's third-largest nonprofit health system, is investing over $800 million in enhanced compensation and benefits for its 165,000+ employees, raising its minimum wage and expanding tuition aid, mental health support, and paid volunteer time.

Jan 30, 2026

Business

Thermo Fisher Beats Q4 Estimates on Product Launches, Acquisitions; Shares Dip Amid Broader Concerns

Thermo Fisher Scientific posted stronger-than-expected Q4 revenue and profit, driven by new products and strategic deals. However, the stock fell as investors weighed pressures in key academic and government markets against the company's solid 2026 outlook.

Jan 30, 2026

Business

Beyond the Bottom Line: One Profitable Stock Worth Watching, Two to Approach with Caution

Profitability alone is no longer a reliable indicator of future success. In today's competitive landscape, companies must balance healthy margins with sustainable growth. We analyze one firm positioned to do just that, and two where investors should look deeper.

Jan 30, 2026

Business

Three Mid-Cap Stocks Facing Headwinds: Why Analysts Are Sounding the Alarm

While mid-cap companies often represent a sweet spot between growth and stability, heightened competition and shifting market dynamics are putting pressure on some notable names. Here’s a closer look at three stocks where caution may be warranted.

Jan 30, 2026

Business

Three Small-Cap Stocks That Give Investors Pause: A Closer Look at the Risks

While small-cap stocks can offer unique growth opportunities away from Wall Street's spotlight, their inherent risks demand careful scrutiny. We examine three companies where valuation concerns and competitive pressures suggest caution may be warranted.

Jan 30, 2026

Business

Beyond the Bottom Line: One Profitable Stock to Watch, Two to Approach with Caution

Profitability is a crucial starting point for investors, but it's not a guaranteed shield against market shifts. As competition evolves, today's cash generators can become tomorrow's laggards. We analyze three companies with strong margins to separate resilient growth from potential stagnation.

Jan 30, 2026

Business

Value Traps: Three 'Bargain' Stocks That May Not Be Worth the Risk

While the allure of finding the next undervalued gem is strong, some stocks trading at low multiples may be cheap for a reason. We examine three companies where fundamental challenges could outweigh their seemingly attractive valuations.

Jan 30, 2026

Business

Dredging Deep: Great Lakes Dredge & Dock Leads Mixed Bag of Q3 Results for Construction Services Sector

As earnings season winds down, the construction and maintenance services sector showed resilience. Great Lakes Dredge & Dock posted solid results despite a revenue miss, while peers like Primoris soared. We analyze the key drivers and what's next for these industrial players.

Jan 30, 2026

Business

Beyond the Bottom Line: How Jacobs and Peers Navigated a Turbulent Q3 in Government Consulting

The third-quarter earnings season reveals a sector at a crossroads. While government and technical consulting firms like Jacobs Solutions benefit from long-term structural trends, their latest financial results and market reactions paint a complex picture of resilience and recalibration.

Jan 30, 2026

Business

iRhythm Holdings Gains Wall Street Favor as Cardiac Monitoring Demand Surges

Morgan Stanley and Evercore ISI reaffirm bullish ratings on iRhythm, citing strong Q4 preliminary results and growth potential from its next-gen cardiac monitoring technology.

Jan 30, 2026

Business

Piper Sandler Bullish on Stryker, Sees 17% Upside Fueled by New Robotic Tech

Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.

Jan 30, 2026

Business

Analysts Trim Targets but See Steady Growth Ahead for Abbott Laboratories

Despite near-term headwinds in its Nutrition segment, Abbott Laboratories (ABT) maintains a bullish long-term outlook with solid organic sales growth projected for 2026, even as major analysts adjust their price targets following Q4 results.

Jan 30, 2026

Business

Medtronic's Growth Outlook Tempered by Survey on Renal Denervation Adoption

A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.

Jan 30, 2026

Business

Visa, Mastercard Remain Skeptical of Stablecoins for Mainstream Payments, Despite Crypto's Promise

The world's largest payment networks are taking a measured approach to stablecoins for everyday consumer transactions, citing a lack of clear demand in developed markets and emphasizing their role as infrastructure providers rather than disruptors.

Jan 30, 2026

Business

Prediction Markets Surge as Coinbase Expands Access and U.S. Regulators Signal Rule Overhaul

A pivotal week for prediction markets saw Coinbase partner with Kalshi to offer event contracts nationwide, while the CFTC moved to establish clearer regulatory standards. Meanwhile, traders sharply increased bets on a potential U.S. government shutdown.

Jan 30, 2026